SCHEMBL6921997

SCHEMBL6921997

Cc1nc(-c2ccc(-c3ccc(C(=O)Nc4ccc5c(c4)OC(CN(C)C)CO5)cc3)c(C)c2)no1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 11/20 0.62
HTR1B P28222 9/20 0.62
HTR2A P28223 9/20 0.62
MAPT P10636 5/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
HPGD P15428 4/20 0.58
TDP1 Q9NUW8 3/20 0.58
TP53 P04637 3/20 0.58
HSD17B10 Q99714 3/20 0.58
ALDH1A1 P00352 3/20 0.58
CYP3A4 P08684 2/20 0.58
CYP2D6 P10635 2/20 0.58
MAPK1 P28482 2/20 0.58
KDM4E B2RXH2 2/20 0.58
CYP1A2 P05177 1/20 0.58
ALOX15 P16050 1/20 0.58
SLC6A4 P31645 3/20 0.57
HTR2C P28335 2/20 0.57
CHRM2 P08172 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6925180 0.97 HTR1D (0.62) HTR1DHTR1BHTR2AMAPTMEN1
SCHEMBL8563220 0.80 HTR1D (0.74) HTR1DHTR1BHTR2AMAPTMEN1
SCHEMBL5582490 0.80 MCHR1 (0.54) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL5582991 0.79 NPC1 (0.56) MAPTMEN1KMT2ATP53ALDH1A1
SCHEMBL8570855 0.78 HTR1D (0.67) HTR1DHTR1BHTR2AMAPTMEN1
SCHEMBL8569674 0.77 HTR1D (1.00) HTR1DHTR1BHTR2AMAPTMEN1
SCHEMBL5582691 0.76 MCHR1 (0.46) HTR1DHTR1BHTR2AMAPTTP53
SCHEMBL8564809 0.76 HTR1D (0.75) HTR1DHTR1BHTR2AMAPTMEN1
SCHEMBL8398370 0.76 HTR1D (0.78) HTR1DHTR1BHTR2AMAPTMEN1
SCHEMBL8562908 0.76 HTR1D (0.91) HTR1DHTR1BHTR2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001766-B1 COMPOUNDS FOR THE TREATMENT OF CCR5-MEDIATED DISEASES SMITHKLINE BEECHAM CORP (US) 2003-04-09 EP claimed
JP-2002511879-A 2002-04-16 JP claimed
EP-1001766-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2001-04-04 EP claimed
EP-1001766-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-05-24 EP claimed
WO-1999001127-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1999-01-14 WO claimed
EP-1001766-B1 COMPOUNDS FOR THE TREATMENT OF CCR5-MEDIATED DISEASES SMITHKLINE BEECHAM CORP (US) 2003-04-09 EP disclosed
US-6515027-B1 Ligands, agonists or antagonists, of the CC chemokine receptor CC-CKR5 SMITHKLINE BEECHAM CORP. 2003-02-04 US disclosed
EP-1001766-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2001-04-04 EP disclosed
EP-1001766-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-05-24 EP disclosed
WO-1999001127-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1999-01-14 WO disclosed